Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08UHS
|
||||
Former ID |
DNC013566
|
||||
Drug Name |
1-(1,4-diacetylphenyl)dithiosemicarbazide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C12H16N6S2
|
||||
Canonical SMILES |
CC(=NNC(=S)N)C1=CC=C(C=C1)C(=NNC(=S)N)C
|
||||
InChI |
1S/C12H16N6S2/c1-7(15-17-11(13)19)9-3-5-10(6-4-9)8(2)16-18-12(14)20/h3-6H,1-2H3,(H3,13,17,19)(H3,14,18,20)/b15-7-,16-8-
|
||||
InChIKey |
IFFLYNGBOLZAGJ-DUGOVBPYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | (S)-reticuline biosynthesis | ||||
Eumelanin biosynthesis | |||||
L-dopachrome biosynthesis | |||||
KEGG Pathway | Tyrosine metabolism | ||||
Riboflavin metabolism | |||||
Metabolic pathways | |||||
Melanogenesis | |||||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References | |||||
REF 1 | Bioorg Med Chem. 2008 Feb 1;16(3):1096-102.1-(1-Arylethylidene)thiosemicarbazide derivatives: a new class of tyrosinase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.